Guest Editor: Liangyu Zou, PhD Professor, Supervisor of PhD student, Vice director, Department of neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University；The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong, China  Email: 2413258252@qq.com Website: https://www.szhospital.com/index?fid=A003&part=localfrm&pk=256&dept_id=329

Dear Colleagues,

Alzheimer's disease is a kind of neuro-degenerative disease occurring in old age and early-old age, it is the most common type of senile dementia manifested by continuous deterioration of memory and cognitive function, progressive decline of daily life ability, a variety of mental symptoms and behavioral disorders. Alzheimer's disease pathology is well characterized by neuroinflammation, neurofibrillary tangles, neuronal loss, and amyloid angiopathy. The exact pathogenesis of Alzheimer's disease is unclear and is believed to be a common result of aging, genetic and environmental factors. Disease modification drugs of Alzheimer’s disease is the key development, including the drug for synaptic plasticity and neuroprotection, treatment for improvement of metabolic disorders and energy imbalance, target for inflammation and vascular factors. In addition, non-drug therapy including acoustic and light stimulation, rTMS, DBS, and cognitive rehabilitation training have all shown some efficacy in the treatment of Alzheimer's disease. This special issue features the treatment of Alzheimer's disease, contributions of this field is welcomed.

Dr. Liangyu Zou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.antpublisher.com through the online submission system. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, Review articles as well as Therapeutic Brief are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. APT is an international peer-reviewed open access quarterly journal published by ANT.

Please visit the Instructions for Authors page before submitting a manuscript. Considering limited grants for some researchers, Dr. Liangyu Zou and the editorial office made the decision that Article Processing Charges will be fully exempted, which means that there is NOT any manuscript processing or publication fees for your article once accepted after standard peer-review.

Submission Deadline

August 30th, 2028

Participants

Xiao Wang, Department of Anatomy and Neurobiology, Guangzhou Medical University, Guangzhou, 510260 China.
Satoru Matsuda, Nara Women’s University, Kita-Uoya Nishimachi, Nara, Japan.
Yao Liu, Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Private Bag 143, Hobart, Tasmania 7001, Australia.
Harpal Buttar, Adjunct Professor, Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ontario, Canada.
Christian Hölscher, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan province, China.
Guiqiong He, Chongqing Key Laboratory of Neurobiology, Chongqing Medical University, Chongqing 400016, China.
Daniela Pechlivanova, Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Baolu Zhao, State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Science, Beijing 100101, China.

Contacts

Updated on December 12, 2022